Navigation Links
Metoprolol in Medical News

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

... For the quarter ended June 27, 2009, net sales of metoprolol succinate reached $306 million, an increase of 173...and price. Par remained the exclusive supplier of metoprolol succinate through the second quarter. Par is the ..., principally driven by the lack of competition in metoprolol succinate and meclizine, as well as the launches o...

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

... its Abbreviated New Drug Applications (ANDAs) for metoprolol succinate extended-release tablets USP in the 25 mg and 50 mg strengths. metoprolol succinate extended-release tablets are the generic...equivalent to AstraZeneca's Toprol XL(R) tablets. metoprolol succinate extended-release is a beta-blocker used ...

AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available

...ket supply of TOPROL-XL and the authorized generic metoprolol succinate following published reports that two gen...c companies had recalled or suspended shipments of metoprolol succinate in late 2008 and early 2009. "After...stributing enough TOPROL-XL and authorized generic metoprolol succinate to meet historical demand levels. The a...

Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009

...For the quarter ended March 28, 2009, net sales of metoprolol succinate reached $112.2 million, an increase of 1...rter of 2009, Par became the exclusive supplier of metoprolol succinate resulting in increased volume and price....he year ago period, principally driven by gains in metoprolol succinate, sumatriptan injection, dronabinol, and ...

Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook

...of alendronate sodium tablets. Generic other revenue decreased $17.8 million to $6.5 million due to a decline in royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg and a decline in royalties from GlaxoSmithKline's sales of Wellbutrin XL(R). Generic gross profit was $1...

Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results

...umatriptan succinate injection, increased sales of metoprolol and Megace(R) ES. For the year ended December 31,...ptan succinate in November, and increased sales of metoprolol succinate to new customers. Gross Margin ... in 2007 driven by increased sales of lower margin metoprolol succinate, lower sales of existing products as men...

Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook

... of new products. Generic other revenue decreased $28.0 million to $2.1 million, due primarily to a decline in royalties related to Sandoz's sales of metoprolol succinate extended-release tablets 50mg. Generic gross profit was $153.0 million, or 41.7 percent of revenue, in the fourth quarter of 2008, co...

Metoprolol Succinate Recalled: Brand Name Drug Scarce But Still Available at Low Cost from Other Countries, PharmacyChecker.com Announces

...alls, many U.S. pharmacies are now out-of-stock of the popular beta-blocker metoprolol succinate. The original, brand name version, Toprol XL, is in very low sup...e Plains, NY (PRWEB) January 30, 2009 -- Consumers who use the beta-blocker metoprolol Succinate ER are scrambling to find medication as a result of recalls by ma...

Watson Pharmaceuticals Reports Third Quarter 2008 Results

...ce erosion on the base business. Generic other revenue decreased $19.9 million to $11.6 million due to a decline in royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg. Generic gross profit was $151.4 million in the third quarter of 2008, compared to $146.8 million in the thi...

KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results

...of fiscal 2009 helped by recent introductions like metoprolol succinate extended-release tablets and our branded...proval and launch of the 50 mg strength of generic metoprolol succinate extended-release tablets in May 2008; an...s of 25 mg, 50 mg, 100 mg, and 200 mg strengths of metoprolol succinate extended-release tablets. At the close...
Metoprolol in Medical Technology

Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)

...NYSE: PRX ) today announced it had begun shipping metoprolol succinate extended release 50 mg tablets. As previ...reement with AstraZeneca in the U.S. to distribute metoprolol succinate extended release tablets, which is subst...to provide a controlled and predictable release of metoprolol for once-daily administration. Annual U.S. sales ...
Metoprolol in Biological News

Gene therapy reversed heart damage in heart failure

...rotein (GFP), and the last group received a saline treatment. One of the ARKct groups and one of the GFP groups also received the beta blocker metoprolol concurrently. Twelve weeks after receiving the treatment, the rats who received the ARKct had a significantly increased left ventricular ej...
Metoprolol in Biological Technology

ETHEX Corporation Issues Nationwide Voluntary Recall of Products

... Hydromorphone HCl Tablets, 8mg (58177-449-04) metoprolol Succinate ER Tablets, 50mg (58177-369-04, 369-09 & 369-11) metoprolol Succinate ER Tablets, 100mg (58177-368-04, 368-09 & 368-11) metoprolol Succinate ER Tablets, 25mg (58177-293-04, 293-09 &...

Watson Pharmaceuticals Reports Second Quarter 2008 Results

...llion sales milestone from Barr Pharmaceuticals, Inc. following a 1999 legal settlement, and reflects the addition of royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg. Generic gross profit was $149.1 million in the second quarter of 2008, compared to $135.3 million in the se...

KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)

...plete Line of All Four Dosage Strengths of Generic metoprolol Succinate Extended-Release Tablets Following Appro...Application (ANDA) to market its 50 mg strength of metoprolol succinate extended-release tablets. The Company ex... the complete line of all four dosage strengths of metoprolol succinate extended-release tablets -- 200 mg, 100 ...

KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis

...nd 200 mg strengths of AstraZeneca's Toprol-XL(R), metoprolol Succinate Extended Release Tablets and to continue...sting product lines. Net revenue contribution from metoprolol Succinate Extended Release Tablets during the seco...007. ETHEX Corporation, with the contribution from metoprolol Succinate Extended Release Tablets launched in Jul...
Other Tags
(Date:7/22/2014)... 22, 2014 For the past nine ... have been working in tandem to help thousands of ... access to care, and help survivors connect to resources ... foundations expanded their partnership to include referrals from PAF ... with the other practical, emotional, and financial issues that ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Get ... the Immune Deficiency Foundation (IDF) to provide ... portal that will allow them to electronically track their ... manage their illnesses. It will also allow those patients ... to consent to have their data shared with ...
(Date:7/22/2014)... Atreo Services will be presenting its full range ... accessories in booth #1423 at the American Society for ... Chicago, Ill., Aug. 3-6. , Atreo will display its ... well as its selection of liners and inserts designed ... In addition, representatives will be available to talk about ...
(Date:7/22/2014)... 2014 Altec Products, Inc. , ... announced today their Gold Sponsorship of Sage Summit ... Bay Hotel and Casino in Las Vegas, Nevada. The ... thousands interested in taking advantage of the many opportunities ... business problems and educate themselves on the latest enterprise ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... to announce the launch of a new website dedicated ... The website can be found at DrKamrava.com . ... provide patients with a knowledgeable and trustworthy source for ... they suffer from hemorrhoids, fissures, gallstones, colon cancer, hernias, ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3
(Date:7/21/2014)... Mark DeCoster, the James E. Wyche III Endowed ... will present as an invited speaker at the ... Research and Development Center in Singapore. , DeCoster, ... Louisiana Tech,s Institute for Micromanufacturing, will present a ... cell and tissue models." The presentation will ...
(Date:7/21/2014)... Medicine-led study suggests that parents of obese children often ... childhood weight gain or the importance of daily physical ... , The study is published online in the ... , "Parents have a hard time changing their child,s ... Rhee, MD, and an assistant adjunct professor in the ...
(Date:7/21/2014)... resistance, and cheating in science are among the ... and mycology experts in Montreal at the three ... July 27 to August 1, 2014. Some 2,000 ... at the 14th International Congress of Bacteriology and ... and Eukaryotic Microbiology, and the 16th International Congress ...
Breaking Biology News(10 mins):Louisiana Tech University professor presents at International Bioprinting Congress 2Parents rank their obese children as 'very healthy' 2Montreal hosts International Union of Microbiology Societies congresses 2
Other Contents